Free Trial

Disc Medicine (IRON) Stock Price, News & Analysis

Disc Medicine logo
$60.35 +0.60 (+1.00%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$61.00 +0.65 (+1.08%)
As of 08/22/2025 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Disc Medicine Stock (NASDAQ:IRON)

Key Stats

Today's Range
$59.75
$61.05
50-Day Range
$50.05
$61.10
52-Week Range
$30.82
$68.73
Volume
349,244 shs
Average Volume
332,509 shs
Market Capitalization
$2.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$98.30
Consensus Rating
Buy

Company Overview

Disc Medicine Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

IRON MarketRank™: 

Disc Medicine scored higher than 70% of companies evaluated by MarketBeat, and ranked 304th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Disc Medicine has received a consensus rating of Buy. The company's average rating score is 3.09, and is based on 10 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Disc Medicine has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Disc Medicine's stock forecast and price target.
  • Earnings Growth

    Earnings for Disc Medicine are expected to decrease in the coming year, from ($4.07) to ($5.01) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Disc Medicine is -13.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Disc Medicine is -13.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Disc Medicine has a P/B Ratio of 3.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Disc Medicine's valuation and earnings.
  • Percentage of Shares Shorted

    10.66% of the float of Disc Medicine has been sold short.
  • Short Interest Ratio / Days to Cover

    Disc Medicine has a short interest ratio ("days to cover") of 6.1.
  • Change versus previous month

    Short interest in Disc Medicine has recently decreased by 20.14%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Disc Medicine does not currently pay a dividend.

  • Dividend Growth

    Disc Medicine does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.66% of the float of Disc Medicine has been sold short.
  • Short Interest Ratio / Days to Cover

    Disc Medicine has a short interest ratio ("days to cover") of 6.1.
  • Change versus previous month

    Short interest in Disc Medicine has recently decreased by 20.14%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Disc Medicine has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Disc Medicine this week, compared to 6 articles on an average week.
  • Search Interest

    11 people have searched for IRON on MarketBeat in the last 30 days. This is an increase of 57% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Disc Medicine insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,866,795.00 in company stock.

  • Percentage Held by Insiders

    Only 3.64% of the stock of Disc Medicine is held by insiders.

  • Percentage Held by Institutions

    83.70% of the stock of Disc Medicine is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Disc Medicine's insider trading history.
Receive IRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Disc Medicine and its competitors with MarketBeat's FREE daily newsletter.

IRON Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
Analysts Set Disc Medicine, Inc. (NASDAQ:IRON) PT at $95.73
Disc Medicine (IRON) Receives a Buy from TD Cowen
See More Headlines

IRON Stock Analysis - Frequently Asked Questions

Disc Medicine's stock was trading at $63.40 at the beginning of the year. Since then, IRON stock has decreased by 4.8% and is now trading at $60.35.

Disc Medicine, Inc. (NASDAQ:IRON) posted its quarterly earnings results on Thursday, August, 7th. The company reported ($1.58) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.17) by $0.41.

Disc Medicine's top institutional shareholders include Frazier Life Sciences Management L.P. (4.78%), JPMorgan Chase & Co. (2.44%), Geode Capital Management LLC (1.73%) and Bain Capital Life Sciences Investors LLC (1.68%). Insiders that own company stock include Venture Fund X LP Atlas, Holdings A/S Novo, Orbimed Advisors Llc, Kevin Bitterman, Mona Ashiya, John D Quisel, Pamela Stephenson, Jean M Franchi, William Jacob Savage, Jonathan Yen-Wen Yu, Rahul Khara, Brian Richard Macdonald, Joanne Bryce and William Richard White.
View institutional ownership trends
.

Shares of IRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Disc Medicine investors own include NVIDIA (NVDA), Broadcom (AVGO), e.l.f. Beauty (ELF), Arista Networks (ANET), Builders FirstSource (BLDR), Novo Nordisk A/S (NVO) and Jabil (JBL).

Company Calendar

Last Earnings
8/07/2025
Today
8/23/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IRON
CIK
1816736
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$132.00
Low Price Target
$75.00
Potential Upside/Downside
+62.9%
Consensus Rating
Buy
Rating Score (0-4)
3.09
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.47)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$109.36 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-26.60%
Return on Assets
-24.58%

Debt

Debt-to-Equity Ratio
0.05
Current Ratio
32.11
Quick Ratio
32.11

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$17.67 per share
Price / Book
3.42

Miscellaneous

Outstanding Shares
34,770,000
Free Float
33,501,000
Market Cap
$2.10 billion
Optionable
Not Optionable
Beta
0.77

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:IRON) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners